OMEROmeros Corp
$10.98
$0.36
(3.17%)
Pre-Market
/filters:format(webp)https://news.stocktwits-cdn.com/large_omeros_jpg_4769b8d291.webp)
EarningsAug 13
Mkt Cap$708.55M
Vol448.00
AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights
H.C. Wainwright reiterated its ‘Buy’ rating on Omeros after AstraZeneca's Phase 3 setback in HSCT-TMA, saying that the outcome improves Yartemlea's competitive positioning.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER PR Newswire NEW YORK, July 23, 2026 NEW YORK, July 23, 2026 /PRNewswire/ -- Pomerantz...
PR Newswire
Omeros (OMER) is Amongst The Best Names Under $10 That Could Yield More Than 200% Return
Omeros (OMER) is Amongst The Best Names Under $10 That Could Yield More Than 200% Return...
Yahoo! Finance: News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER PR Newswire NEW YORK, July 9, 2026 NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz...
PR Newswire
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
Key PointsHeartflow uses artificial intelligence to transform coronary imaging into actionable diagnostic data for heart disease...
Nasdaq News: Markets
OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Omeros Corporation (Omeros or the Company) (NASDAQ: OMER) for violations of the securities laws.The investigation focuses on whether the Company issued false...
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER PR Newswire NEW YORK, July 1, 2026 NEW YORK, July 1, 2026 /PRNewswire/ -- Pomerantz...
PR Newswire
Noteworthy Friday Option Activity: OMER, QCOM, REPL
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Omeros Corp (Symbol: OMER), where a total of 11,925 contracts have traded so far, representing approximately 1.2 million underlying shares. That amounts to about 60.6% o...
Nasdaq News: Markets
FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide
EMA rejects Omeros' Yartemlea for TA-TMA, citing insufficient efficacy data, despite FDA approval and U.S. launch.read more...
Benzinga
<
1
2
>
Advertisement|Remove ads.
Latest OMER News
ViewAstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights
Stocktwits
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
PR Newswire
Omeros (OMER) is Amongst The Best Names Under $10 That Could Yield More Than 200% Return
Yahoo! Finance: News
DIA14
27
QQQ46
85
MSTR5
12Advertisement|Remove ads.